DNA X, Inc. (SONM): Revenue

Annual figures by period end, from SEC filings.

$58.30M
Year ended 2024-12-31
+2.2%
3-year compound annual growth
-12.9%
5-year compound annual growth
$135.66M2018-12-31: $135.66M2019-12-31: $116.25M2020-12-31: $63.99M2021-12-31: $54.57M2022-12-31: $69.83M2023-12-31: $93.63M2024-12-31: $58.30M$58.30M
2018-12-31 Revenue (USD) 2024-12-31
Period endedRevenueChange YoYSource filing
2024-12-31$58.30M-37.7%2025-03-31, From 2024-01-01
2023-12-31$93.63M+34.1%2025-03-31, From 2023-01-01
2022-12-31$69.83M+28.0%2024-03-27, From 2022-01-01
2021-12-31$54.57M-14.7%2023-03-20, From 2021-01-01
2020-12-31$63.99M-45.0%2022-06-29, From 2020-01-01
2019-12-31$116.25M-14.3%2021-03-18, From 2019-01-01
2018-12-31$135.66Mn/a2020-03-27, From 2018-01-01